MedPath

Impact of Medical Follow-up Discharge Package

Not Applicable
Withdrawn
Conditions
Follow-up Study
Medical In-patients
Interventions
Other: Integrated medical follow-up package
Registration Number
NCT01916876
Lead Sponsor
University of Cape Town
Brief Summary

The post discharge time is a vulnerable time for general medical in-patients, with high rates of adverse events that may cause unnecessary readmissions and even death. A recent study of 415 patients discharged from the general medical wards at Groote Schuur Hospital, demonstrated a very high 12 month mortality of 35%. The majority of these deaths were classified as "unexpected". The reasons for this were not further examined, but it was speculated, given the authors' knowledge of the public sector in Cape Town, that three related factors contribute significantly to this early mortality: i) a lack of continuity of care, with patients not necessarily accessing the primary care support treatment that they need or being able to access early post discharge follow-up (for example for anti-retroviral or anti-tuberculous care); ii) the inability of primary care to deal with the complex nature of the discharged patients, most whom have significant co-morbid disease; iii) A lack of optimisation of therapy for chronic disease after acute discharge.

The investigators hypothesise that an integrated post-discharge transitional care package, which includes an early medical specialist follow-up in the first 3 months after hospital discharge will decrease the 6- and 12-month mortality and re-admission rate amongst general medical hospital admissions in Cape Town, South Africa. Our study will compare an integrated package, suitable to implementation if effective, with current standard discharge packages.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Patients referred for admission to general medical wards (including within hospital transfer e.g. ICU discharge)
  2. >18 years and willing to give informed consent
Exclusion Criteria
  1. Patient admitted directly to intensive care unit
  2. Patient refusing consent or <18 years old
  3. Patients electively admitted
  4. Patients without phone numbers who cannot provide any telephone contact details for a co-habitant, relative or neighbour.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Integrative medical follow-up packageIntegrated medical follow-up packageAt discharge, patients will receive a discharge plan by their attending caregiver. Thereafter, if randomised to this study arm they will receive the intervention as outlined elsewhere. "Integrated Medical Follow-up package"
Primary Outcome Measures
NameTimeMethod
All cause mortality12 months

All cause 12-month mortality will be evaluated at 12-months post enrolment. Data on mortality will be acquired through telephonic patient/family contact and review of provincial death registry

Secondary Outcome Measures
NameTimeMethod
All cause mortality6 months

6-month mortality will be evaluated in a similar way to 12-month mortality.

Hospital readmission rate12 months

Readmission to secondary, tertiary hospitals or emergency units will be included.

Bartel index12 months

The change in functional outcome between discharge and 12-months will be measured using the Bartel index.

Karnofsky performance score12 months

Changes in functional outcomes will be assessed by measuring the change in Karnofsky performance scores between 12-months and pre-admission.

Trial Locations

Locations (2)

Victoria Hospital

🇿🇦

Cape Town, South Africa

Groote Schuur Hospital

🇿🇦

Cape Town, South Africa

© Copyright 2025. All Rights Reserved by MedPath